Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor.
作者信息
Gambato Martina, Burra Patrizia
机构信息
Multivisceral Transplant Unit, Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
出版信息
Updates Surg. 2020 Jun;72(2):237-239. doi: 10.1007/s13304-020-00804-8.
Abstract
摘要
相似文献
1
Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor.新型冠状病毒肺炎对慢性肝病和肝肿瘤患者的临床影响
Updates Surg. 2020 Jun;72(2):237-239. doi: 10.1007/s13304-020-00804-8.
2
Management of Hepatocellular Cancer in the time of SARS-CoV-2.2019冠状病毒病时期肝细胞癌的管理
Liver Int. 2020 Aug;40(8):1823-1825. doi: 10.1111/liv.14517.
3
Management of liver diseases during the pandemic of coronavirus disease-19.2019冠状病毒病大流行期间的肝病管理
Clin Mol Hepatol. 2020 Jul;26(3):243-250. doi: 10.3350/cmh.2020.0111. Epub 2020 Jun 23.
4
"Long covid": the Dutch response.“长期新冠”：荷兰的应对措施。
BMJ. 2020 Aug 14;370:m3202. doi: 10.1136/bmj.m3202.
5
From doctors as patients: a manifesto for tackling persisting symptoms of covid-19.从医生作为患者的角度：应对新冠长期症状的宣言。
BMJ. 2020 Sep 15;370:m3565. doi: 10.1136/bmj.m3565.
6
The JCF in the Time of COVID-19.新冠疫情时期的日本临床肿瘤学会（JCF）
J Card Fail. 2020 Jun;26(6):447. doi: 10.1016/j.cardfail.2020.06.004.
7
Managing Your Chronic Lung Disease during the COVID-19 Pandemic.在新冠疫情期间管理您的慢性肺病
Am J Respir Crit Care Med. 2020 Jul 15;202(2):P5-P6. doi: 10.1164/rccm.2020C8.
8
Management of Patients with Liver Transplant and Chronic Liver Diseases During COVID-19 Pandemic: A Brief Review.COVID-19 大流行期间肝移植和慢性肝病患者的管理：简要综述。
Arch Iran Med. 2020 Oct 1;23(10):713-717. doi: 10.34172/aim.2020.92.
9
Experience of a small country (Montenegro) in the COVID-19 epidemic and its impact on rehabilitation.一个小国（黑山）在新冠疫情中的经历及其对康复的影响。
Eur J Phys Rehabil Med. 2020 Jun;56(3):367-368. doi: 10.23736/S1973-9087.20.06352-2. Epub 2020 May 8.
10
The impact of COVID-19 on rehabilitation: the Belgian experience.新冠疫情对康复的影响：比利时的经验
Eur J Phys Rehabil Med. 2020 Jun;56(3):371-372. doi: 10.23736/S1973-9087.20.06400-X.
引用本文的文献
1
IGSF1: a biomarker for predicting prognosis, immunotherapy response, and drug candidates in COVID-19 combined hepatocellular carcinoma.IGSF1：一种用于预测COVID-19合并肝细胞癌预后、免疫治疗反应及候选药物的生物标志物。
Discov Oncol. 2024 Oct 29;15(1):599. doi: 10.1007/s12672-024-01483-2.
2
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma.严重急性呼吸综合征冠状病毒2型大流行对肝细胞癌患者管理的影响
J Clin Med. 2022 Jul 31;11(15):4475. doi: 10.3390/jcm11154475.
3
Liver dysfunction and SARS-CoV-2 infection.肝功能障碍与 SARS-CoV-2 感染。
World J Gastroenterol. 2021 Jul 14;27(26):3951-3970. doi: 10.3748/wjg.v27.i26.3951.
4
Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know?肝损伤、新型冠状病毒感染与2019冠状病毒病：医生究竟应该了解什么？
GastroHep. 2021 May;3(3):121-130. doi: 10.1002/ygh2.455. Epub 2021 May 3.
5
A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection.新型冠状病毒感染康复后失代偿期酒精性肝病的高难度肝移植手术。
Transpl Int. 2021 Apr;34(4):756-757. doi: 10.1111/tri.13842. Epub 2021 Feb 27.
6
SARS-CoV-2 Vaccine Development: An Overview and Perspectives.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗研发：概述与展望
ACS Pharmacol Transl Sci. 2020 Sep 18;3(5):844-858. doi: 10.1021/acsptsci.0c00109. eCollection 2020 Oct 9.
本文引用的文献
1
Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).新型严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）导致的慢性肝衰竭急性发作。
Liver Int. 2020 Jul;40(7):1590-1593. doi: 10.1111/liv.14506. Epub 2020 May 20.
2
Management of hepatocellular carcinoma in the time of COVID-19.2019冠状病毒病时期肝细胞癌的管理
Ann Oncol. 2020 Aug;31(8):1084-1085. doi: 10.1016/j.annonc.2020.04.007. Epub 2020 Apr 21.
3
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis.2019 年冠状病毒病与慢性肝病的流行情况：一项荟萃分析。
Liver Int. 2020 Jun;40(6):1316-1320. doi: 10.1111/liv.14465. Epub 2020 Apr 24.
4
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.2019冠状病毒病大流行期间肝病患者的护理：欧洲肝脏研究学会-欧洲临床微生物学与传染病学会立场文件
JHEP Rep. 2020 Jun;2(3):100113. doi: 10.1016/j.jhepr.2020.100113. Epub 2020 Apr 2.
5
Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations.2019年冠状病毒病大流行期间癌症手术病例的管理：注意事项
Ann Surg Oncol. 2020 Jun;27(6):1717-1720. doi: 10.1245/s10434-020-08461-2. Epub 2020 Apr 8.
6
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.COVID-19 感染癌症患者的临床特征：中国武汉三家医院的回顾性病例研究。
Ann Oncol. 2020 Jul;31(7):894-901. doi: 10.1016/j.annonc.2020.03.296. Epub 2020 Mar 26.
7
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.SARS-CoV-2 在武汉一家三级医院癌症患者中的传播。
JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.
8
COVID-19 and the liver: little cause for concern.新冠病毒与肝脏：无需过度担忧。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):529-530. doi: 10.1016/S2468-1253(20)30084-4. Epub 2020 Mar 20.
9
Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.失代偿期肝硬化患者中新型冠状病毒2型感染的预防
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):528-529. doi: 10.1016/S2468-1253(20)30080-7. Epub 2020 Mar 17.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件